Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $8.72 USD
Change Today +0.16 / 1.87%
Volume 90.7K
CCXI On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 06/2/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitleKey Developments
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitle
Joseph Feczko M.D. 35 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Roger Lucas Ph.D. 31 RelationshipsLead Independent Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
CCXI Compensation vs. Industry
550.0K
373.5K
Chief Executive Officer
400.0K
272.6K
Chief Financial Officer
Share price activity for CHEMOCENTRYX INC (CCXI)
52 Week Price Performance
CCXI
Industry Average

Nominating Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitleKey Developments
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeChemoCentryx Appoints Israel F. Charo, Senior Vice President of Research
09/22/14
Roger Lucas Ph.D. 31 RelationshipsLead Independent Director, Member of Nominating & Corporate Governance Committee and Member of Compensation CommitteeChemoCentryx, Inc. Appoints Anne-Marie S. Duliege as Executive Vice President, Chief of Strategic Development and Head of Immuno-Oncology
03/27/14
Joseph Feczko M.D. 35 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance CommitteeEdward Penhoet Intends to Resign from Board of Directors of ChemoCentryx, Inc
07/5/13

Corporate Governance Committee* - chemocentryx inc (CCXI)

Name (Connections)Board RelationshipsTitle
Joseph Feczko M.D. 35 RelationshipsDirector, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee
Roger Lucas Ph.D. 31 RelationshipsLead Independent Director, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee
James Tyree 45 RelationshipsDirector, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
CCXI and Competitor
Insiders vs. External
Board
6%
94%
ChemoCentryx, Inc.
Insiders
External Board Members

Advisory Committee* - chemocentryx inc (CCXI)

Name (Board Relationships)/Title Board Affiliations
Craig Gerard 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Hanauer 71 Relationships
Member of Clinical Advisory Board
No other board affiliations
Michael Kamm 15 Relationships
Member of Clinical Advisory Board
No other board affiliations
Daniel Littman 169 Relationships
Member of Scientific Advisory Board
No other board affiliations
Edward Mocarski 32 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Ransohoff 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
William Sandborn 154 Relationships
Member of Clinical Advisory Board
No other board affiliations
Henry Showell 15 Relationships
Member of Scientific Advisory Board
No other board affiliations
Stephen Targan 56 Relationships
Member of Clinical Advisory Board
No other board affiliations
Sander van Deventer 83 Relationships
Member of Clinical Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCXI:US $8.72 USD +0.16

CCXI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CCXI.
View Industry Companies
 

Industry Analysis

CCXI

Industry Average

Valuation CCXI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 3.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMOCENTRYX INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.